Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Total other segment expense, net

Other segment segments

North American Pharmaceutical
$85.87B
Oncology & Multispecialty
$13.9B
Prescription Technology Solutions
$1.34B+13.5%

Similar metrics at other companies

Medtronic logo
MDTMedical Surgical — Other segment items
$5M+25.0%
Surgery Partners, Inc. logo
SGRYSurgical Facilities — Other segment items
$84.2M+14.6%
ABM Industries logo
ABMTechnical Solutions — Other segment expense
$91.7M+26.8%
California Resources logo
CRCTotal Reportable Segments — Other segment expenses
$60M-1.6%
Mirion Technologies logo
MIRMedical Segment — Other segment items
$39.3M-3.4%
Scholastic logo
SCHLTotal Education Solutions — Other segment items
$900K+50.0%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$102.7B+16.8%
Enterprise value$110.42B+14.5%
P/E22.4×-5.4×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)Three Months Ended June 30, 2026Three Months Ended June 30, 2025
North American Pharmaceutical (3)$85,870$82,135
Oncology & Multispecialty13,89710,446
Prescription Technology Solutions (4)1,3401,181
Medical-Surgical Solutions (5)2,6972,480
Other292
Total other segment expense, net$103,804$96,534
Segment operating profit
North American Pharmaceutical$903$594

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's medical-surgical solutions — total other segment expense, net?
McKesson (MCK) reported medical-surgical solutions — total other segment expense, net of $2.7B in Q2 2026.
How has McKesson's medical-surgical solutions — total other segment expense, net changed year-over-year?
McKesson's medical-surgical solutions — total other segment expense, net increased by 8.8% year-over-year, from $2.48B to $2.7B.
What is the long-term trend for McKesson's medical-surgical solutions — total other segment expense, net?
Over 3 years (2023 to 2026), McKesson's medical-surgical solutions — total other segment expense, net has grown at a 1.9% compound annual growth rate (CAGR), from $9.99B to $10.57B.
What does medical-surgical solutions — total other segment expense, net mean?
Captures the net total of various expenses incurred by the Medical-Surgical Solutions segment that are not classified as cost of goods sold or operating expenses. This includes items like administrative overhead allocations or specific segment-level costs. It is used to reconcile segment operating income to total segment performance.

Ask your AI about McKesson's medical-surgical solutions — total other segment expense, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude